Table of Contents:

1 Report Prologue
2 Introduction
2.1 Definition
2.2 Scope of the Study
2.3 Research Objectives
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
2.5 Market Structure
3 Research Methodology
3.1 Primary Research Methodology
3.2 Secondary Research Methodology
3.3 Market Size Estimation
3.4 Forecast Model
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 High Prevalence of Chronic Diseases
4.2.2 Technological Advancements
4.3 Restraints
4.3.1 Product Recalls
4.4 Challenge
4.4.1 Stringent Regulations
4.5 Mega Trend
4.5.1 Technological Trends
4.6 Macroeconomics
5 Market Factor Analysis
5.1 Porter's Five Forces Model
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.2.1 R&D
5.2.2 Manufacturing
5.2.3 Distribution & Sales
5.2.4 Post-Sales Monitoring
5.3 Demand & Supply: Gap Analysis
5.4 Pricing Analysis
6 Global Prefilled Syringes Market, by Material
6.1 Introduction
6.2 Glass Prefilled Syringes
6.2.1 Oil-Siliconized Syringes
6.2.2 Baked-On Silicone Syringes
6.3 Plastic Syringes
7 Global Prefilled Syringes Market, by Type
7.1 Introduction
7.2 Conventional Prefilled Syringes
7.3 Safety Prefilled Syringes
8 Global Prefilled Syringes Market, by Design
8.1 Introduction
8.2 Single-Chamber Prefilled Syringes
8.3 Dual-Chamber Prefilled Syringes
8.4 Customized Prefilled Syringes
9 Global Prefilled Syringes Market, by End User
9.1 Introduction
9.2 Hospitals/Clinics
9.3 Ambulatory Surgical Centers
10 Global Prefilled Syringes, by Region
10.1 Introduction
10.2 Europe
10.2.1 Western Europe
10.2.1.1 Germany
10.2.1.2 France
10.2.1.3 UK
10.2.1.4 Italy
10.2.1.5 Spain
10.2.1.6 Rest of Western Europe
10.2.2 Eastern Europe
10.3 Americas
10.3.1 North America
10.3.1.1 US
10.3.1.2 Canada
10.3.2 South America
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia-Pacific
10.5 Middle East & Africa
10.5.1 Middle East
10.5.2 Africa
11 Competitive Landscape
11.1 Introduction
12 Company Profiles
12.1 Gerresheimer AG
12.1.1 Company Overview
12.1.2 Financial Overview
12.1.3 Products Offering
12.1.4 Key Developments
12.1.5 SWOT Analysis
12.1.6 Key Strategy
12.2 Schott AG
12.2.1 Company Overview
12.2.2 Financial Overview
12.2.3 Products Offering
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.2.6 Key Strategy
12.3 Medtronic
12.3.1 Company Overview
12.3.2 Financial Overview
12.3.3 Products Offering
12.3.4 Key Developments
12.3.5 SWOT Analysis
12.3.6 Key Strategy
12.4 Terumo Corporation
12.4.1 Company Overview
12.4.2 Financial Overview
12.4.3 Products Offering
12.4.4 Key Developments
12.4.5 SWOT Analysis
12.4.6 Key Strategy
12.5 Abbott
12.5.1 Company Overview
12.5.2 Financial Overview
12.5.3 Products Offering
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.5.6 Key Strategy
12.6 Nipro Corporation
12.6.1 Company Overview
12.6.2 Financial Overview
12.6.3 Products Offering
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.6.6 Key Strategy
12.7 Baxter
12.7.1 Company Overview
12.7.2 Financial Overview
12.7.3 Products Offering
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.7.6 Key Strategy
12.8 Becton, Dickinson and Company
12.8.1 Company Overview
12.8.2 Financial Overview
12.8.3 Products Offering
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.8.6 Key Strategy
12.9 West Pharmaceutical
12.9.1 Company Overview
12.9.2 Financial Overview
12.9.3 Products Offering
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.9.6 Key Strategy
12.1 Weigao Group
12.10.1 Company Overview
12.10.2 Financial Overview
12.10.3 Products Offering
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.10.6 Key Strategy
12.11 Vetter Pharma International GmbH
12.11.1 Company Overview
12.11.2 Financial Overview
12.11.3 Products Offering
12.11.4 Key Developments
12.11.5 SWOT Analysis
12.11.6 Key Strategy
12.12 OMPI (A Stevanato Group Company)
12.12.1 Company Overview
12.12.2 Financial Overview
12.12.3 Products Offering
12.12.4 Key Developments
12.12.5 SWOT Analysis
12.12.6 Key Strategy
13 Conclusion
13.1 Key Findings
13.1.1 CEO's Viewpoint
13.1.2 Unmet Needs
13.1.3 Key Companies to Watch
13.1.4 Prediction for the Prefilled Syringes Industry
14 Appendix
14.1 Discussion Blueprint
14.2 Recent Key Developments
14.3 References